371 related articles for article (PubMed ID: 32001619)
1. The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.
Yang H; Xiang S; Kazi A; Sebti SM
J Biol Chem; 2020 Mar; 295(10):3055-3063. PubMed ID: 32001619
[TBL] [Abstract][Full Text] [Related]
2. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.
Tecleab A; Zhang X; Sebti SM
J Biol Chem; 2014 Nov; 289(45):31296-309. PubMed ID: 25210032
[TBL] [Abstract][Full Text] [Related]
3. Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK.
Wang J; Hu K; Guo J; Cheng F; Lv J; Jiang W; Lu W; Liu J; Pang X; Liu M
Nat Commun; 2016 May; 7():11363. PubMed ID: 27193833
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
[TBL] [Abstract][Full Text] [Related]
5. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
DeNicola GM; Karreth FA; Humpton TJ; Gopinathan A; Wei C; Frese K; Mangal D; Yu KH; Yeo CJ; Calhoun ES; Scrimieri F; Winter JM; Hruban RH; Iacobuzio-Donahue C; Kern SE; Blair IA; Tuveson DA
Nature; 2011 Jul; 475(7354):106-9. PubMed ID: 21734707
[TBL] [Abstract][Full Text] [Related]
6. Nrf2-lncRNA controls cell fate by modulating p53-dependent Nrf2 activation as an miRNA sponge for Plk2 and p21
Joo MS; Shin SB; Kim EJ; Koo JH; Yim H; Kim SG
FASEB J; 2019 Jul; 33(7):7953-7969. PubMed ID: 30897343
[TBL] [Abstract][Full Text] [Related]
7. NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression.
Chen D; Tavana O; Chu B; Erber L; Chen Y; Baer R; Gu W
Mol Cell; 2017 Oct; 68(1):224-232.e4. PubMed ID: 28985506
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor belinostat regulates metabolic reprogramming in killing KRAS-mutant human lung cancer cells.
Peter RM; Sarwar MS; Mostafa SZ; Wang Y; Su X; Kong AN
Mol Carcinog; 2023 Aug; 62(8):1136-1146. PubMed ID: 37144836
[TBL] [Abstract][Full Text] [Related]
10. Activation of Akt and JNK/Nrf2/NQO1 pathway contributes to the protective effect of coptisine against AAPH-induced oxidative stress.
Hu YR; Ma H; Zou ZY; He K; Xiao YB; Wang Y; Feng M; Ye XL; Li XG
Biomed Pharmacother; 2017 Jan; 85():313-322. PubMed ID: 27903425
[TBL] [Abstract][Full Text] [Related]
11. Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells.
Yang X; Wang D; Ma Y; Xu X; Zhu Z; Wang X; Deng H; Li C; Chen M; Tong J; Yamanaka K; An Y
Toxicol Appl Pharmacol; 2015 Dec; 289(2):231-9. PubMed ID: 26420645
[TBL] [Abstract][Full Text] [Related]
12. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress.
Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J
Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038
[TBL] [Abstract][Full Text] [Related]
13. P21
Han D; Gao J; Gu X; Hengstler JG; Zhang L; Shahid M; Ali T; Han B
Arch Toxicol; 2018 Feb; 92(2):679-692. PubMed ID: 28940008
[TBL] [Abstract][Full Text] [Related]
14. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
15. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
16. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
[TBL] [Abstract][Full Text] [Related]
17. IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways.
Song NY; Zhu F; Wang Z; Willette-Brown J; Xi S; Sun Z; Su L; Wu X; Ma B; Nussinov R; Xia X; Schrump DS; Johnson PF; Karin M; Hu Y
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E812-E821. PubMed ID: 29311298
[TBL] [Abstract][Full Text] [Related]
18. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells.
Deng X; Rui W; Zhang F; Ding W
Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690
[TBL] [Abstract][Full Text] [Related]
19. The ROS-KRAS-Nrf2 axis in the control of the redox homeostasis and the intersection with survival-apoptosis pathways: Implications for photodynamic therapy.
Ferino A; Rapozzi V; Xodo LE
J Photochem Photobiol B; 2020 Jan; 202():111672. PubMed ID: 31778952
[TBL] [Abstract][Full Text] [Related]
20. The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage.
Sfikas A; Batsi C; Tselikou E; Vartholomatos G; Monokrousos N; Pappas P; Christoforidis S; Tzavaras T; Kanavaros P; Gorgoulis VG; Marcu KB; Kolettas E
Cell Signal; 2012 Nov; 24(11):2007-23. PubMed ID: 22750558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
